Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The acquisition of SPR Therapeutics will allow Medtronic to expand its portfolio of neuromodulator medical devices. The deal is expected to close in 2027.
These third-party marketers earn commissions from their insurer clients not only upon initial signups but also every time “their” enrollees renew without changing plans.
The agency cited free speech as its reasoning for rescinding the long-standing policy. While in place, the rule barred companies that agreed to settlements with the Securities and Exchange Commission from publicly denying allegations made by regulators.
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
The Food and Drug Administration granted 510(k) pre-market notification for a new diagnostic imaging tool that reports to look deep into diseased tissue.
It’s no surprise that men would prefer not to receive a colonoscopy, but just how much they prefer the alternative CT colonography was the subject of a study in the current issue of The Lancet.
With the age of digital imaging comes new considerations that radiologists had not previously thought about, such as resolution size of a digital image.
Radsite, one of the leaders in improving quality among imaging facilities, announced that it has reviewed more than 60,000 imaging systems and about 23,000 facilities.
Researchers looking at a national survey of 600 hospitals found the uninsured and Medicaid enrollees receive fewer medical imaging procedures during emergency room visits.
Breast cancer screening made the list of 26 Medicaid quality measures that states may begin reporting to the Centers for Medicare and Medicaid Services next year. Measurements excluded other forms of diagnostic imaging.